XEDEV is a Contract Research Organisation (CRO) and Contract Development and Manufacturing Organisation (CDMO) specialised in formulation and process development for solid dosage forms. The company provides comprehensive support for the pharmaceutical, biotechnology, chemical, and food industries, focusing on the development of early-phase formulations through to clinical phase products across various administration routes.

Services include:
– Contract Development and Manufacturing (CDMO)
– Contract Research
– Formulation and process development of drug products via drying, granulation, tableting, and coating processes
– Analytical tools for characterising drug substances and products
– Solid state and powder/tablet characterisation
– Assay and purity analysis
– Clinical batch productions up to phase IIb

XEDEV is committed to delivering high-quality services tailored to the needs of its clients in the pharmaceutical sector. For more information, please visit xedev.com.